T1D Exchange, Inc.
Boston, MA
- UEI
- PTHNFHJWZ8E6
- CAGE
- 79U92
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- SAM.gov registration date
- Physical address
- 101 Federal St #440, Boston, MA 02110, USA
- Website
- t1dexchange.org
- Founded
- 2010
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Vanderbilt University Medical Center | U01DK137533 | $31,161 | |
| Vanderbilt University Medical Center | U01DK137533 | $31,161 | |
| Vanderbilt University Medical Center | U01DK137533 | $91,011 | |
| Vanderbilt University Medical Center | U01DK137533 | $139,505 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| APC Community Services | NY | 813319 Other Social Advocacy Organizations |
| Finance | Boston, MA | 621111 Offices of Physicians (except Mental Health Specialists) |
| Lankenau Institute For Medical Research | Wynnewood, PA | — |
| Community Health Center Network, Inc. | San Leandro, CA | — |
| Jaeb Center For Health Research Foundation, Inc. | Tampa, FL | — |
About the company
T1D Exchange, Inc., a Boston-based tax-exempt nonprofit organization, operates as a sub-recipient on federal research grants focused on diabetes and COVID-19 assessment, with all three recent awards (100% of footprint) flowing through Vanderbilt University Medical Center as the prime grantee. The organization has no prime contract or grant awards and no seats on federal contract vehicles; its entire federal footprint consists of sub-award work under the Department of Health and Human Services National Institute of Diabetes and Digestive and Kidney Diseases.
T1D Exchange's recent federal work centers on the CODA (COVID and Diabetes Assessment) research initiative. Three sub-award agreements from NIDDK, channeled through Vanderbilt University Medical Center, total $262 thousand in combined obligations: awards dated December 28, 2023; November 13, 2024; and April 14, 2026. The organization's activity has maintained a steady cadence of one award per year across 2023, 2024, and 2026, with no apparent growth or contraction in recent cycles.
As a nonprofit sub-recipient rather than a prime contractor or direct grantee, T1D Exchange occupies a specialized research-support role within a single federal customer's diabetes and infectious-disease research portfolio. The modest award volume and dollar scale, combined with 100% concentration in NIDDK sub-awards, reflects either early-stage or narrowly focused federal engagement. No recompete cliff, vehicle positioning, or prime teaming relationships are present in the award footprint.
Quick answers
Is T1D Exchange, Inc. registered in SAM.gov?
Yes. T1D Exchange, Inc.'s SAM.gov registration is active through April 8, 2027.
On GovTribe
See T1D Exchange, Inc.'s full federal record
- Similar vendors